Answer
Tecentriq (atezolizumab) concentrate for solution for infusion is contraindicated in patients with hypersensitivity to atezolizumab or any excipient listed in section 6.1.
Sources for this answer
- Tecentriq 840 mg and 1,200 mg concentrate for solution for infusionRoche Products Limited · emc · SmPC §4.3 Contraindications · Version 44Document updated
Sources checked